Promisia Healthcare Limited logo

Ongoing Disclosure Notices

Insider Disclosure31 March 2017PHLHealthcare

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Promisia Integrative Ltd

Date this disclosure made:

31-Mar-17

Date of last disclosure:

-

Director or senior manager giving disclosure

Full name(s):

Thomas David Brankin

(Thomas)

Name of listed issuer:

Promisia Integrative Ltd

Name of related body corporate (if applicable):

NA

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares

Nature of the affected relevant interest(s):

Beneficial owner and

registered holder

For that relevant interest-

Number held in class before acquisition or disposal:

46,304,210

Number held in class after acquisition or disposal:

48,804,210

Current registered holder(s):

Charles Oliver Daily and

Justine O'Sullivan and

Christopher Ritchie

Registered holder(s) once transfers are registered:

Thomas and Michael Lay

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

NA

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: One (1)

Details of transactions requiring disclosure-

Date of transaction:27-Mar-17

Nature of transaction:

Off market acquisition of

shares

Name of any other party or parties to the transaction (if known):
Charles Oliver Daily and

Justine O'Sullivan and

Christopher Ritchie

The consideration, expressed in New Zealand dollars, paid or received for the acquisition

or disposal. If the consideration was not in cash and cannot be readily by converted into a

cash value, describe the consideration:

$0.04 per share, being

$100,000 in aggregate

Number of financial products to which the transaction related: 2,500,000

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:NA

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

NA

Date of the prior written clearance (if any):

NA

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:Nil

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

31-Mar-17

Name and title of authorised person:Matt Yates, Solicitor

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Promisia Integrative Ltd

Date this disclosure made:

31-Mar-17

Date of last disclosure:

-

Director or senior manager giving disclosure

Full name(s):

Maurice Duncan Priest

(Duncan)

Name of listed issuer:

Promisia Integrative Ltd

Name of related body corporate (if applicable):

NA

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares

Nature of the affected relevant interest(s):

Register holder

For that relevant interest-

Number held in class before acquisition or disposal:

9,336,315

Number held in class after acquisition or disposal:

9,836,315

Current registered holder(s):

Charles Oliver Daily and

Justine O'Sullivan and

Christopher Ritchie

Registered holder(s) once transfers are registered:

Duncan

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

NA

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: One (1)

Details of transactions requiring disclosure-

Date of transaction:27-Mar-17

Nature of transaction:

Off market acquisition of

shares

Name of any other party or parties to the transaction (if known):

Charles Oliver Daily and

Justine O'Sullivan and

Christopher Ritchie

The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a

cash value, describe the consideration:

$0.04 per share, being in

aggregate $20,000

Number of financial products to which the transaction related: 500,000

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:NA

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

NA

Date of the prior written clearance (if any):

NA

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:Nil

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

31-Mar-17

Name and title of authorised person:Matt Yates, Solicitor

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Promisia Integrative Ltd

Date this disclosure made:

31-Mar-17

Date of last disclosure:

-

Director or senior manager giving disclosure

Full name(s):

Charles Oliver Daily (Charles)

Name of listed issuer:

Promisia Integrative Ltd

Name of related body corporate (if applicable):

NA

Position held in listed issuer:

Chief Executive Officer (resigned)

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares

Nature of the affected relevant interest(s):

Beneficial owner and registered holder

For that relevant interest-

Number held in class before acquisition or disposal:

21,517,647

Number held in class after acquisition or disposal:

7,142,647

Current registered holder(s):

Charles and Justine O'Sullivan and Christopher

Ritchie

Registered holder(s) once transfers are registered:

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

NA

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: Fourteen (14)

Details of transactions requiring disclosure-

Date of transactions:27-Mar-17

Nature of transactions: Off market disposal of shares

Name of any other party or parties to the transactions (if known):

GREGORY DEAN HUTTON, JILLIAN MARY OBRIEN,

THOMAS DAVID BRANKIN AND MICHAEL JOHN

KIRWIN LAY, DYLAN JOSHUA ROBINSON, PHILIP

MCVEIGH, ROBERT DONALD ANGUS, JOHN

DANIEL BARNETT, OLIVER THOMAS BRANKIN,

WAYNE NOEL LUXTON, BRENT WILLIAM JAMES

ANDERSON, THOMAS JAMES BARNES, SAMUEL

ROBERT PRIEST, MAURICE DUNCAN PRIEST,

JULIE ANN SIMPSON

The consideration, expressed in New Zealand dollars, paid or received for the acquisition

or disposal. If the consideration was not in cash and cannot be readily by converted into a

cash value, describe the consideration:$0.04 per share, being in aggregate $575,000

Number of financial products to which the transaction related: 14,375,000

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:NA

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

NA

Date of the prior written clearance (if any):

NA

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:Nil

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Certification
I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

31-Mar-17

Name and title of authorised person:Matt Yates, Solicitor

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.